CCT7 is a subunit of the TRiC/CCT chaperonin complex, an eight-subunit molecular machine that facilitates ATP-dependent protein folding 1. As part of the negatively charged hemisphere of the TRiC chamber 1, CCT7 participates in folding critical cytoskeletal proteins including actin and tubulin, with hierarchical assembly ensuring proper complex architecture and functional properties 1. In spermatogenesis, CCT7 cooperates with the germ cell-specific cofactor STYXL1 to regulate tubulin folding for flagellar development and male fertility 2. Beyond structural proteins, CCT7 mediates maturation of G protein-coupled receptors by preventing aggregation and promoting proper trafficking 3. The CCT7 apical domain independently inhibits tau aggregation, a hallmark of Alzheimer's disease, through direct substrate interaction 4. During cellular stress, CCT7 regulates TFEB, a master regulator of autophagy and lysosomal biogenesis, in response to lysosomal damage 5. Clinically, CCT7 overexpression correlates with hepatocellular carcinoma progression and poor prognosis, with higher diagnostic and prognostic value than alpha-fetoprotein in early-stage disease 6. CCT7 has been identified as a potential dual biomarker for both atherosclerotic cardiovascular disease and metastatic prostate cancer 7.